Cargando…

The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine

BACKGROUND: An important contribution to well-being of human beings can be observed by the use of self-medication products that is reflected in the constantly growing volume of over-the-counter (OTC) drugs. The aim of the current study was to extend the measurement concept for OTCs by exploring the...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetz, Katja, Kalder, Matthias, Albert, Ute-Susann, Jacke, Christian O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359243/
https://www.ncbi.nlm.nih.gov/pubmed/32660646
http://dx.doi.org/10.1186/s12913-020-05501-1
_version_ 1783559007285280768
author Goetz, Katja
Kalder, Matthias
Albert, Ute-Susann
Jacke, Christian O.
author_facet Goetz, Katja
Kalder, Matthias
Albert, Ute-Susann
Jacke, Christian O.
author_sort Goetz, Katja
collection PubMed
description BACKGROUND: An important contribution to well-being of human beings can be observed by the use of self-medication products that is reflected in the constantly growing volume of over-the-counter (OTC) drugs. The aim of the current study was to extend the measurement concept for OTCs by exploring the relevance of the peripheral assortment provided by the widely accepted framework of the Anatomical Therapeutical and Chemical (ATC) classification of the WHO. METHODS: The focus was on the prescriptions and drug-related receipts submitted by privately insured persons to 18 private health insurers (PHIs) in Germany from the year 2016. The age- and gender-specific average claims amount per risks of outpatient drug expenditure were used as weights to scale up the relative distributions of the item amounts. The ATC-classification defines the commodity groups and discriminates between the main and the peripheral assortment. A descriptive analysis assessed the OTC frequencies and sum scores of the product groups within the main and peripheral assortment whereby the study group explored and assessed the relevance of each category independently according to the OTCs and integrative medicines. RESULTS: The analysis included 22.1 Mio. packages from the main assortment and examined 10.1 Mio. packages from the peripheral assortment. The latter was examined thoroughly and the commodity groups “Pharmaceutical food products”, “Medicinal products for special therapy options” and particular “Hygiene and body care products” meet the defined requirements for OTCs relevant for integrative medicines. A high proportion of OTC products from the peripheral assortment was associated with the categories “medicinal products for special therapy options”. Homeopathy and anthroposophy present two special therapy options, which are relevant for the extended OTC measurement. CONCLUSIONS: The analysis of OTC drugs is feasible when the main and the peripheral assortment is available and enable to integrate about 18% of all OTCs, which are neglected by the common ATC-based approach. The presented extended approach may help to identify potential users of OTCs or people in need of OTC use. In case of the highly disputed homeopathy and anthroposophy products, more research among interactions with prescriptions drugs (Rx), nutrition’s and other potentially harmful exposures is recommended.
format Online
Article
Text
id pubmed-7359243
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73592432020-07-17 The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine Goetz, Katja Kalder, Matthias Albert, Ute-Susann Jacke, Christian O. BMC Health Serv Res Research Article BACKGROUND: An important contribution to well-being of human beings can be observed by the use of self-medication products that is reflected in the constantly growing volume of over-the-counter (OTC) drugs. The aim of the current study was to extend the measurement concept for OTCs by exploring the relevance of the peripheral assortment provided by the widely accepted framework of the Anatomical Therapeutical and Chemical (ATC) classification of the WHO. METHODS: The focus was on the prescriptions and drug-related receipts submitted by privately insured persons to 18 private health insurers (PHIs) in Germany from the year 2016. The age- and gender-specific average claims amount per risks of outpatient drug expenditure were used as weights to scale up the relative distributions of the item amounts. The ATC-classification defines the commodity groups and discriminates between the main and the peripheral assortment. A descriptive analysis assessed the OTC frequencies and sum scores of the product groups within the main and peripheral assortment whereby the study group explored and assessed the relevance of each category independently according to the OTCs and integrative medicines. RESULTS: The analysis included 22.1 Mio. packages from the main assortment and examined 10.1 Mio. packages from the peripheral assortment. The latter was examined thoroughly and the commodity groups “Pharmaceutical food products”, “Medicinal products for special therapy options” and particular “Hygiene and body care products” meet the defined requirements for OTCs relevant for integrative medicines. A high proportion of OTC products from the peripheral assortment was associated with the categories “medicinal products for special therapy options”. Homeopathy and anthroposophy present two special therapy options, which are relevant for the extended OTC measurement. CONCLUSIONS: The analysis of OTC drugs is feasible when the main and the peripheral assortment is available and enable to integrate about 18% of all OTCs, which are neglected by the common ATC-based approach. The presented extended approach may help to identify potential users of OTCs or people in need of OTC use. In case of the highly disputed homeopathy and anthroposophy products, more research among interactions with prescriptions drugs (Rx), nutrition’s and other potentially harmful exposures is recommended. BioMed Central 2020-07-13 /pmc/articles/PMC7359243/ /pubmed/32660646 http://dx.doi.org/10.1186/s12913-020-05501-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Goetz, Katja
Kalder, Matthias
Albert, Ute-Susann
Jacke, Christian O.
The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine
title The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine
title_full The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine
title_fullStr The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine
title_full_unstemmed The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine
title_short The usage of over-the-counter products by private insured patients in Germany – a claims data analysis with focus on complementary medicine
title_sort usage of over-the-counter products by private insured patients in germany – a claims data analysis with focus on complementary medicine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359243/
https://www.ncbi.nlm.nih.gov/pubmed/32660646
http://dx.doi.org/10.1186/s12913-020-05501-1
work_keys_str_mv AT goetzkatja theusageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT kaldermatthias theusageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT albertutesusann theusageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT jackechristiano theusageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT goetzkatja usageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT kaldermatthias usageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT albertutesusann usageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine
AT jackechristiano usageofoverthecounterproductsbyprivateinsuredpatientsingermanyaclaimsdataanalysiswithfocusoncomplementarymedicine